UK markets closed

Axsome Therapeutics, Inc. (0HKF.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
72.42+1.44 (+2.03%)
At close: 04:13PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 316.98%
S&P500 52-week change 323.06%
52-week high 398.17
52-week low 355.64
50-day moving average 385.35
200-day moving average 375.30

Share statistics

Avg vol (3-month) 3562
Avg vol (10-day) 3357
Shares outstanding 529.81M
Implied shares outstanding 6N/A
Float 834.88M
% held by insiders 117.12%
% held by institutions 183.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -88.41%
Operating margin (ttm)-77.68%

Management effectiveness

Return on assets (ttm)-24.86%
Return on equity (ttm)-159.21%

Income statement

Revenue (ttm)270.6M
Revenue per share (ttm)5.96
Quarterly revenue growth (yoy)193.50%
Gross profit (ttm)N/A
EBITDA -182.45M
Net income avi to common (ttm)-239.24M
Diluted EPS (ttm)-3.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)386.19M
Total cash per share (mrq)8.15
Total debt (mrq)186.37M
Total debt/equity (mrq)97.59%
Current ratio (mrq)3.63
Book value per share (mrq)4.03

Cash flow statement

Operating cash flow (ttm)-145.08M
Levered free cash flow (ttm)-78.72M